Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2025-12-24 @ 7:56 PM
NCT ID:
NCT00904904
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be planning to undergo cataract surgery on one eye by phacoemulsification with posterior chamber intraocular lens, using topical or general anaesthesia.
* Subjects must have a preoperative flare ≤ 15 ph/ms, measured with a laser flare meter(LFM) without pharmacological pupil dilation, within the 2 months preoperatively.
Exclusion Criteria:
* Subjects who have any progressive pathology requiring the use of topical or systemic anti-inflammatory or anti-infectious agents.
* Subjects who take acetylsalicylic acid at doses \> 100 mg daily and cannot discontinue usage during the study.
* Subjects who have a history of asthma linked to acetylsalicylic acid or other nonsteroidal anti-inflammatory (NSAI) drug administration.
* Subjects with immunodepression.
* Subjects with a history of intolerance to the study drug or to any NSAI drug.
* Subjects who are monocular for any reason other than cataract.
* Subjects who are treated with local or systemic anti-inflammatory drugs within 10 days prior to inclusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00904904
Study Brief:
Protocol Section:
NCT00904904